Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–2025
Lakshmi Panagiotakopoulos(Centers for Disease Control and Prevention), Megan Wallace(Centers for Disease Control and Prevention), Danielle Moulia(Centers for Disease Control and Prevention), Oliver Brooks, Ruth Link‐Gelles(Centers for Disease Control and Prevention), Katherine E. Fleming-Dutra(Centers for Disease Control and Prevention), Monica Godfrey, Fiona P. Havers(Centers for Disease Control and Prevention), Lauren Roper, H. Keipp Talbot(Marshfield Clinic), Shannon Stokley(National Center for Immunization and Respiratory Diseases), Robert Schechter(California Health and Human Services Agency), Christopher A. Taylor(Centers for Disease Control and Prevention), Matthew F. Daley(Kaiser Permanente)
Cited by 82
Related Papers
Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011
|JAMA|2016|1.8k
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
|JAMA Internal Medicine|2020|747
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic — United States, 2020–2021
|MMWR Morbidity and Mortality Weekly Report|2021|611
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602